Virbac S.A.
General ticker "VRBCF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - General
- Capitalization: $2.9B (TTM average)
Virbac S.A. follows the US Stock Market performance with the rate: 25.8%.
Estimated limits based on current volatility of 0.0%: low 384.75$, high 384.75$
Factors to consider:
- Company pays dividends (annually): last record date 2025-06-25, amount 1.70$ (Y0.44%)
Short-term VRBCF quotes
Long-term VRBCF plot
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | €1,464.13MM |
| Operating Expenses | €1,246.06MM |
| Operating Income | €218.07MM |
| Non-Operating Income | €-0.46MM |
| Interest Expense | €8.62MM |
| Income(Loss) | €217.61MM |
| Taxes | €67.22MM |
| Profit(Loss)* | €150.83MM |
| Stockholders Equity | €1,124.77MM |
| Inventory | €378.65MM |
| Assets | €1,913.45MM |
| Operating Cash Flow | €195.57MM |
| Capital expenditure | €92.20MM |
| Investing Cash Flow | €-199.48MM |
| Financing Cash Flow | €-5.53MM |
| Earnings Per Share** | €17.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.